{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:53:39Z","timestamp":1783464819902,"version":"3.55.0"},"reference-count":24,"publisher":"Tsinghua University Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.26599\/1671-5411.2025.01.007","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T07:46:57Z","timestamp":1746690417000},"page":"169-177","source":"Crossref","is-referenced-by-count":2,"title":["Amyloid deposits in prostate biopsy as an opportunity to diagnose early cardiac amyloidosis"],"prefix":"10.26599","volume":"22","author":[{"given":"Mar\u00eda","family":"Cesp\u00f3n-Fern\u00e1ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar Jos\u00e9","family":"Escalona-Canal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"S\u00e1nchez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Raposeiras-Roub\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e1mer","family":"Abdulkader-Sande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Jos\u00e9","family":"Cobas-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Torreira-Banzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emad","family":"Abu-Assi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Teijeira-Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Dom\u00ednguez-Aristegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Garc\u00eda-Pav\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Eugenia","family":"Escalona-Canal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Cesp\u00f3n-Outeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Ortiz-Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11138","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/ejhf.2140","article-title":"Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"23","author":"P Garcia-Pavia","year":"2021","unstructured":"P Garcia-Pavia. Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. 2021, 23: 512-526.","journal-title":"Eur J Heart Fail"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"361","DOI":"10.26599\/1671-5411.2023.05.006","article-title":"Cardiac amyloidosis: state-of-the-art review","volume":"20","author":"S Bukhari","year":"2023","unstructured":"S Bukhari. Cardiac amyloidosis: state-of-the-art review. 2023, 20: 361-375.","journal-title":"J Geriatr Cardiol"},{"key":"ref3","first-page":"102","article-title":"A systematic review and meta-analysis of the prevalence of transthyretin amyloidosis in heart failure with preserved ejection fraction","volume":"12","author":"M Magdi","year":"2022","unstructured":"M Magdi. A systematic review and meta-analysis of the prevalence of transthyretin amyloidosis in heart failure with preserved ejection fraction. 2022, 12: 102-111.","journal-title":"American journal of cardiovascular disease"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"FL Ruberg","year":"2019","unstructured":"FL Ruberg. Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review. 2019, 73: 2872-2891.","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1161\/CIRCULATIONAHA.118.038169","article-title":"Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis","volume":"140","author":"T Lane","year":"2019","unstructured":"T Lane. Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis. 2019, 140: 16-26.","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1002\/ejhf.2974","article-title":"Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms","volume":"25","author":"P Elliott","year":"2023","unstructured":"P Elliott. Improved long-term survival with tafamidis treatment in patients with transthyretin amyloid cardiomyopathy and severe heart failure symptoms. 2023, 25: 2060-2064.","journal-title":"Eur J Heart Fail"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"MS Maurer","year":"2018","unstructured":"MS Maurer. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. 2018, 379: 1007-1016.","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1177\/1756287219870074","author":"","unstructured":"","journal-title":"null"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"102229","DOI":"10.1016\/j.eucr.2022.102229","article-title":"Isolated prostate amyloidosis; a case report","volume":"45","author":"RR Sibley","year":"2022","unstructured":"RR Sibley. Isolated prostate amyloidosis; a case report. 2022, 45: 102229.","journal-title":"Urol Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.urology.2020.08.053","article-title":"The Clinical Implication of Incidental Prostatic Amyloidosis","volume":"145","author":"A Nevo","year":"2020","unstructured":"A Nevo. The Clinical Implication of Incidental Prostatic Amyloidosis. 2020, 145: 253-257.","journal-title":"Urology"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1111\/his.14717","article-title":"Clinical relevance of amyloid in prostate samples: a report on 40 patients","volume":"81","author":"MP Foix","year":"2022","unstructured":"MP Foix. Clinical relevance of amyloid in prostate samples: a report on 40 patients. 2022, 81: 363-370.","journal-title":"Histopathology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"P Garcia-Pavia","year":"2021","unstructured":"P Garcia-Pavia. Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases. 2021, 42: 1554-1568.","journal-title":"Eur Heart J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent","volume":"79","author":"N Mottet","year":"2021","unstructured":"N Mottet. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. 2021, 79: 243-262.","journal-title":"Eur Urol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.urology.2021.12.008","article-title":"Localized amyloidosis of the seminal tract is not associated with subsequent development of systemic amyloidosis","volume":"164","author":"I Nemov","year":"2022","unstructured":"I Nemov. Localized amyloidosis of the seminal tract is not associated with subsequent development of systemic amyloidosis. 2022, 164: 46-49.","journal-title":"Urology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/13506129.2022.2147636","article-title":"Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee","volume":"29","author":"JN Buxbaum","year":"2022","unstructured":"JN Buxbaum. Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee. 2022, 29: 213-219.","journal-title":"Amyloid"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1111\/j.1442-2042.2004.00921.x","article-title":"Implications of amyloidosis on prostatic biopsy","volume":"11","author":"N Lawrentschuk","year":"2004","unstructured":"N Lawrentschuk. Implications of amyloidosis on prostatic biopsy. 2004, 11: 925-927.","journal-title":"Int J Urol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s11255-005-2088-x","article-title":"Localized primary amyloidosis of the prostate, bladder and ureters","volume":"37","author":"SK Singh","year":"2005","unstructured":"SK Singh. Localized primary amyloidosis of the prostate, bladder and ureters. 2005, 37: 495-497.","journal-title":"Int Urol Nephrol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0022-5347(17)60202-7","article-title":"Amyloid deposition in the prostate","volume":"110","author":"SK Wilson","year":"1973","unstructured":"SK Wilson. Amyloid deposition in the prostate. 1973, 110: 322-323.","journal-title":"J Urol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"117418","DOI":"10.1016\/j.jns.2021.117418","article-title":"The prostate as a good candidate organ for proving amyloid deposition in non-endemic late onset hereditary transthyretin amyloidosis: Report of two cases","volume":"424","author":"K Maeda","year":"2021","unstructured":"K Maeda. The prostate as a good candidate organ for proving amyloid deposition in non-endemic late onset hereditary transthyretin amyloidosis: Report of two cases. 2021, 424: 117418.","journal-title":"J Neurol Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13506129.2019.1582023","article-title":"Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation","volume":"26","author":"H Koike","year":"2019","unstructured":"H Koike. Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation. 2019, 26: 13-14.","journal-title":"Amyloid"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.rec.2017.11.017","article-title":"Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis","volume":"72","author":"T Ripoll-Vera","year":"2019","unstructured":"T Ripoll-Vera. Cardiac Involvement in a Patient Cohort With Val30Met Mutation Transthyretin Amyloidosis. 2019, 72: 92-94.","journal-title":"Revista espanola de cardiologia (English ed)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"MM Kittleson. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee. 2023, 81: 1076-1126.","journal-title":"J Am Coll Cardiol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"JD Gillmore","year":"2016","unstructured":"JD Gillmore. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. 2016, 133: 2404-2012.","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1002\/ehf2.13130","article-title":"Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis","volume":"8","author":"S Dasari","year":"2021","unstructured":"S Dasari. Non-cardiac biopsy sites with high frequency of transthyretin amyloidosis. 2021, 8: 750-755.","journal-title":"ESC Heart Fail"}],"container-title":["Journal of Geriatric Cardiology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T05:35:07Z","timestamp":1746768907000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciopen.com\/article\/10.26599\/1671-5411.2025.01.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"URL":"https:\/\/doi.org\/10.26599\/1671-5411.2025.01.007","relation":{},"ISSN":["1671-5411"],"issn-type":[{"value":"1671-5411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]}}}